NCT00817778 Study to Assess the Safety and Tolerability After Multiple Oral Doses of AZD1656 in Patients With Type 2 Diabetes Mellitus Treated With Metformin Status COMPLETED Phase PHASE2
NCT00817323 What is the Antidepressant Mechanism of Action of Quetiapine in Bipolar Depression? Status WITHDRAWN Phase PHASE3
NCT00815659 Effect of Crestor (Rosuvastatin) on Lipid Levels in Patients With Metabolic Syndrome Status COMPLETED Phase PHASE4
NCT00813306 14473 - D9126C00001 Proof of Principle Study - Effect of AZD2066 on Transient Lower Esophageal Sphincter Relaxations Status COMPLETED Phase PHASE1/PHASE2
NCT00812955 Safety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol ("Bad Cholesterol") and Triglycerides Status COMPLETED Phase PHASE3
NCT00812682 Physician and Patient Perception of Adjustable Maintenance Dosing of Symbicort Turbuhaler Status COMPLETED Phase N/A
NCT00812357 Symbicort Usage in Asthma Treatment and Impact of a New Therapeutic Strategy on Compliance and Asthma Control in France Status COMPLETED Phase N/A
NCT00812045 Study to Assess Efficacy of AZD1236 in Patients With Cystic Fibrosis Status WITHDRAWN Phase PHASE2
NCT00811369 Trial to Evaluate the Therapeutic Benefit of Fulvestrant in Combination With ZACTIMA in Postmenopausal Women With Bone Predominant, Hormone Receptor Positive Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00809731 Observational Study to Evaluate Efficacy and Remission Status for Schizophrenia Patients Under Atypical Treatment Status COMPLETED Phase N/A
NCT00808678 Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) and Rosuvastatin Calcium Status COMPLETED Phase PHASE1
NCT00808249 AZD7325 Proof of Concept in Patients With Generalized Anxiety Disorder (GAD) Status COMPLETED Phase PHASE2
NCT00807937 Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)AZD7325 Status COMPLETED Phase PHASE2